Key Record Dates Identifier: NCT01886469
Brief Title: A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)

First Submitted : June 21, 2013
First Submitted that Met QC Criteria : June 25, 2013
First Posted : June 26, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : October 2, 2014
Last Update Posted : October 3, 2014 (Estimate)